We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.53B
AUM Growth
+$98M
Cap. Flow
-$58.3M
Cap. Flow %
-1.65%
Top 10 Hldgs %
13.53%
Holding
1,397
New
118
Increased
442
Reduced
608
Closed
107

Top Buys

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$9.97M
2
XOM icon
ExxonMobil
XOM
+$5.65M
3
UPS icon
United Parcel Service
UPS
+$4.33M
4
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$4.28M
5
JPM icon
JPMorgan Chase
JPM
+$3.89M

Top Sells

Rank Stock Value
1
FINL
Finish Line
FINL
+$14.5M
2
SE
Spectra Energy Corp Wi
SE
+$9.83M
3
MENT
Mentor Graphics Corp
MENT
+$8.3M
4
META icon
Meta Platforms (Facebook)
META
+$4.95M
5
UAL icon
United Airlines
UAL
+$4.76M

Sector Composition

Rank Sector Weight
1 Healthcare 12.97%
2 Financials 11.54%
3 Technology 10.61%
4 Industrials 9.38%
5 Consumer Discretionary 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCIH
1251
DELISTED
Chinacache International Holdings Ltd
CCIH
$92K ﹤0.01%
59,141
+1,392
+2% +$3.13K
PIR
1252
DELISTED
Pier 1 Imports, Inc.
PIR
$90K ﹤0.01%
626
-150
-19% -$22K
ALLT icon
1253
Allot
ALLT
$367M
$89K ﹤0.01%
18,600
– –
ECF
1254
Ellsworth Growth & Income Fund
ECF
$167M
$87K ﹤0.01%
+10,104
New +$86.4K
LYG icon
1255
Lloyds Banking Group
LYG
$90.7B
$85K ﹤0.01%
24,982
– –
TCRT icon
1256
Alaunos Therapeutics
TCRT
$4.59M
$75K ﹤0.01%
80
-120
-60% -$112K
TPST icon
1257
Tempest Therapeutics
TPST
$13.8M
$66K ﹤0.01%
12
-3
-20% -$14K
XNET
1258
Xunlei
XNET
$360M
$57K ﹤0.01%
14,000
– –
FUEL
1259
DELISTED
Rocket Fuel Inc.
FUEL
$55K ﹤0.01%
10,235
-1,600
-14% -$4.66K
OIG
1260
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$53K ﹤0.01%
282
– –
GGB icon
1261
Gerdau
GGB
$9.74B
$48K ﹤0.01%
17,640
– –
IBRX icon
1262
ImmunityBio
IBRX
$7.8B
$39K ﹤0.01%
+11,100
New +$54.8K
SDLP
1263
DELISTED
SEADRILL PARTNERS LLC
SDLP
$39K ﹤0.01%
1,088
-497
-31% -$20.3K
SCU
1264
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$36K ﹤0.01%
1,600
– –
AXAS
1265
DELISTED
Abraxas Petroleum Corp
AXAS
$35K ﹤0.01%
875
-750
-46% -$34.3K
VSLR
1266
DELISTED
VIVINT SOLAR, INC.
VSLR
$34K ﹤0.01%
12,000
+2,000
+20% +$6K
PDLI
1267
DELISTED
PDL BioPharma, Inc.
PDLI
$34K ﹤0.01%
15,188
-500
-3% -$1.11K
NGD
1268
DELISTED
New Gold Inc
NGD
$32K ﹤0.01%
+10,818
New +$35K
EVEP
1269
DELISTED
EV Energy Partners, L.P.
EVEP
$31K ﹤0.01%
20,977
-5,308
-20% -$9.51K
ZNGA
1270
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$29K ﹤0.01%
10,275
-4,600
-31% -$12.4K
TWNKW
1271
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
$28K ﹤0.01%
10,000
– –
ARQL
1272
DELISTED
Arqule Inc
ARQL
$28K ﹤0.01%
26,000
– –
BNSO
1273
DELISTED
Bonso Electronic International
BNSO
$26K ﹤0.01%
10,000
-10,000
-50% -$23.9K
GSAT icon
1274
Globalstar
GSAT
$10.3B
$24K ﹤0.01%
1,014
– –
NEON icon
1275
Neonode
NEON
$13.4M
$24K ﹤0.01%
1,500
– –
49 50
51
52 53

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q1 2017 Portfolio in Review

As of Q1 2017, Oppenheimer & Co held 1,397 positions worth $3.53B, up 2.9% from $3.44B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q1 2017 filing shows 118 new, 442 increased, 608 reduced and 107 closed positions. Its largest new stake was Robert Half: 53,601 shares worth $2.62M. The largest sale was Finish Line, an estimated $14.5M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q1 2017 buy was Robert Half: 53,601 shares worth $2.62M.
  • Oppenheimer & Co added most to Enbridge in Q1 2017, an estimated $9.97M increase.
  • Oppenheimer & Co's biggest Q1 2017 reduction was Finish Line, cutting an estimated $14.5M.
  • Oppenheimer & Co fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $9.83M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.53B portfolio in Q1 2017.
  • Oppenheimer & Co opened 118 new positions and closed 107 in Q1 2017.
  • Oppenheimer & Co's portfolio value rose 2.9% quarter-over-quarter to $3.53B.

Based on Oppenheimer & Co's 13F filing for Q1 2017, filed 15 May 2017.